POUR LA VICTOIRE ‼️
THE MONTRÉAL VICTOIRE ARE THE 2026 PWHL WALTER CUP CHAMPIONS!
LA VICTOIRE DE MONTRÉAL SONT LES CHAMPIONNES DE LA COUPE WALTER 2026 DE LA LPHF!
We are heading to the CAR-TCR Summit by @HansonWade in Boston this week! Don't miss:
· Catherine Tomaro-Duchesneau's presentation on Wed Sept 24 at 11:25 AM
· Barbara Ressler taking part in the Tech Slam – Wed Sept 24 at 3:35 PM
· Our scientific poster
https://t.co/IY06qOpK1A
Excited to be at the @HansonWade CAR-TCR Summit in Boston this week! I’ll be speaking and providing insights for how a CDMO, like @RoslinCT, can help scale cell therapies. Looking forward to reconnecting with colleagues and meeting new ones! #CARTCR#CellTherapy
We are heading to the CAR-TCR Summit by @HansonWade in Boston this week! Don't miss:
· Catherine Tomaro-Duchesneau's presentation on Wed Sept 24 at 11:25 AM
· Barbara Ressler taking part in the Tech Slam – Wed Sept 24 at 3:35 PM
· Our scientific poster
https://t.co/IY06qOpK1A
Don’t miss our Senior Director of Manufacturing & MS&T joining a thought-provoking panel discussion alongside Leopold Bertea, CTO, Mendus and Rui Tostoes, VP CMC, ImmuneBridge.
Thursday, June 12 at 11:30 am
Panel Discussion: Key Considerations for Commercial Scale Manufacturing
Don't miss Catherine Tomaro-Duchesneau, PhD, Senior Director of Manufacturing and MS&T at RoslinCT, delivering the keynote at Proteintech Group’s Cell Therapy Symposium on May 29th!
🔗 Free Registration: https://t.co/jn5tD2YuLH
Catherine Tomaro-Duchesneau, PhD, Senior Director of Manufacturing and MS&T at RoslinCT, will deliver the keynote at @Proteintech Group’s Cell Therapy Symposium!
🗓️ Date: May 29, 2025
🔗 Free Registration: https://t.co/jn5tD2YuLH
Only a week to go!
Join us and learn how leading scientists and industry experts are tackling the scaling from research to real-world cell therapy.🧬
📅 29th May
🕒 9 AM CDT | 3 PM BST | 4 PM CEST
🔗 FREE registration! https://t.co/Tuq6RKemoi
#CellTherapy#ProteintechEvents
Catherine Tomaro-Duchesneau, PhD, Senior Director of Manufacturing and MS&T at RoslinCT, will deliver the keynote at @Proteintech Group’s Cell Therapy Symposium!
🗓️ Date: May 29, 2025
🔗 Free Registration: https://t.co/jn5tD2YuLH
RoslinCT has entered into a strategic partnership with Gamida Cell to manufacture their FDA-Approved Cell Therapy Omisirge®, a commercial product for the treatment of hematologic malignancies.
Read the full press release here: https://t.co/yfLenqhOGI